85 related articles for article (PubMed ID: 2236453)
1. Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
Dunlop SR; Dornseif BE; Wernicke JF; Potvin JH
Psychopharmacol Bull; 1990; 26(2):173-80. PubMed ID: 2236453
[TBL] [Abstract][Full Text] [Related]
2. Pattern analysis of antidepressant response to fluoxetine.
Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
Zajecka JM; Jeffries H; Fawcett J
J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
[TBL] [Abstract][Full Text] [Related]
4. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
de Jonghe F; Ravelli DP; Tuynman-Qua H
Pharmacopsychiatry; 1991 Mar; 24(2):62-7. PubMed ID: 1852793
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine treatment of dysthymia in the elderly.
Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine and desipramine in major depressive disorder.
Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Wagner G
J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
[TBL] [Abstract][Full Text] [Related]
15. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
16. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine once every third day in the treatment of major depressive disorder.
Tural U; Onder E
Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
[TBL] [Abstract][Full Text] [Related]
18. Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder.
von Bardeleben U; Holsboer F; Gerken A; Benkert O
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():31-5. PubMed ID: 2644337
[TBL] [Abstract][Full Text] [Related]
19. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.
Beasley CM; Bosomworth JC; Wernicke JF
Psychopharmacol Bull; 1990; 26(1):18-24. PubMed ID: 2196623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
